Fuchs endothelial corneal dystrophy

Ocular Surface

Volumn 8, Issue 4, 2010, Pages 173-184

  Elhalis, Hussain ^a,b   Azizi, Behrooz ^a,b   Jurkunas, Ula V ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antioxidants; Apoptosis; Collagen VIII; Corneal endothelium; Fuchs endothelial corneal dystrophy; Genetics; Oxidative stress; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADVANCED GLYCATION END PRODUCT; CLUSTERIN; COLLAGEN TYPE 8; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BIOMICROSCOPY; BLURRED VISION; CONGENITAL DISORDER; CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY; CORNEA DISEASE; CORNEA DYSTROPHY; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; DESCEMET MEMBRANE; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; FUCHS ENDOTHELIAL CORNEAL DYSTROPHY; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETICS; HEREDITY; HISTOPATHOLOGY; HUMAN; MISSENSE MUTATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; POINT MUTATION; PREVALENCE; PROTEOMICS; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; VISION; VISUAL IMPAIRMENT;

EID: 79951864480     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70232-X     Document Type: Review

References (112)

1. Fuchs E. Dystrophia epithelialis corneae. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1910;76:478-508
2. Iwamoto T, DeVoe AG. Electron microscopic studies on Fuchs'combined dystrophy. I. Posterior portion of the cornea. Invest Ophthalmol 1971;10:9-28
3. Waring GO III, Rodrigues MM, Laibson PR. Corneal dystrophies. II. Endothelial dystrophies. Surv Ophthalmol 1978;23:147-68 (Pubitemid 9092514)
4. Waring GO III, Rodrigues MM, Laibson PR. Corneal dystrophies, in Leibowitz HM (ed). Corneal disorders: clinical diagnosis and management. Philadelphia PA, Saunders, 1984
5. Weisenthal RW, Streeten BW. Posterior membrane dystrophies, in Krachmer JH, Mannis MH, Holland E J (eds). Cornea, Volume II: Cornea andeExternal disease, clinical diagnosis and management. St Louis MO, Mosby-Year Book, 1997
6. Adamis AP, Filatov V, Tripathi BJ, Tripathi RC. Fuchs' endothelial dystrophy of the cornea. Surv Ophthalmol 1993;38:149-68 (Pubitemid 23297229)
7. Waring GO III, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology 1982;89:531-90 (Pubitemid 12085989)
8. Miller CA, Krachmer JH. Endothelial dystrophies, in Kaufman HE, Barron BA, McDonald M B, Waltman SR (eds). The cornea. New York, Churchill-Livingstone, 1988
9. Arffa RC. Disorders of the endothelium, in Arffa RC (ed). Grayson's diseases of the cornea. St Louis MO, Mosby-Year Book, 1991
10. Bourne WM. Fuchs' corneal dystrophy, in Fraunfelder FT, Roy FH (eds). Current ocular therapy. Philadelphia PA, Saunders, 1995
11. Yanoff M, Fine BS. Ocular pathology. Barcelona, Mosby-Wolfe, 1996, pp 276-8
12. Wilson SE, Bourne WM. Fuchs' dystrophy. Cornea 1988;7:2-18
13. Abbott RL, Fine BS, Webster RG Jr, et al. Specular microscopic and histologic observations in nonguttate corneal endothelial degeneration. Ophthalmology 1981;88:788-800 (Pubitemid 11039466)
14. Lloyd RI. Less evident causes of lowered acuity in senility. Am J Ophthalmol 1944;27:232-43
15. Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am J Ophthalmol 1967;64:1155-8
16. Goar EL. Dystrophy of the corneal endothelium (cornea guttata), with a report of a histological examination. Am J Ophthalmol 1934;17:215
17. Kuwabara T, Quevedo AR, Cogan DG. An experimental study of dichloroethane poisoning. Arch Ophthalmol 1968;79:321-30
18. Kanai A, Kaufman HE. The retrocorneal ridge in syphilitic and herpetic interstitial keratitis: an electron-microscopic study. Ann Ophthalmol 1982;14:120-4 (Pubitemid 12152795)
19. Renard G, Dhermy P, Pouliquen Y. [Secondary dystrophies of corneal endothelium and Descemet's membrane: histological and ultrastructural study (author's transl)]. J Fr Ophtalmol 1981;4:721-39. French
20. Waring GO, Font RL, Rodrigues MM, Mulberger RD. Alterations of Descemet's membrane in interstitial keratitis. Am J Ophthalmol 1976;81:773-85
21. Edmonds C, Iwamoto T. Electron microscopy of late interstitial keratitis. Ann Ophthalmol 1972;4:693-6
22. Weiss JS, Moller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. Cornea 2008;27 Suppl 2:S1-83
23. Cross HE, Maumenee AE, Cantolino SJ. Inheritance of Fuchs' endothelial dystrophy. Arch Ophthalmol 1971;85:268-72
24. Rosenblum P, Stark WJ, Maumenee IH, et al. Hereditary Fuchs' dystrophy. Am J Ophthalmol 1980;90:455-62
25. Magovern M, Beauchamp GR, McTigue JW, et al. Inheritance of Fuchs' combined dystrophy. Ophthalmology 1979;86:1897-1923
26. Krachmer JH, Purcell JJ Jr, Young CW, Bucher KD. Corneal endothelial dystrophy. A study of 64 families. Arch Ophthalmol 1978;96:2036-9 (Pubitemid 8404086)
27. Santo RM, Yamaguchi T, Kanai A, et al. Clinical and histopathologic features of corneal dystrophies in Japan. Ophthalmology 1995;102:557-67
28. Vithana EN, Morgan PE, Ramprasad V, et al. SLC 4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet 2008;17:656-66 (Pubitemid 351292255)
29. Becker B, Shafer RN. Diagnosis and therapy of the glaucomas. St Louis, CV Mosby, 1976, pp 265-6
30. Buxton JN, Preston RW, Riechers R, Guilbault N. Tonography in cornea guttata. A preliminary report. Arch Ophthalmol 1967;77:602-3
31. Roberts CW, Steinert RF, Thomas JV, Boruchoff SA. Endothelial guttata and facility of aqueous outflow. Cornea 1984;3:5-9 (Pubitemid 15176601)
32. del Buey MA, Cristobal JA, Ascaso FJ, et al. Biomechanical properties of the cornea in Fuchs' corneal dystrophy. Invest Ophthalmol Vis Sci 2009;50:3199-202
33. Terry MA, Shamie N, Chen ES, et al. Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure. Ophthalmology 2009;116:631-39
34. Lipman RM, Rubenstein JB, Torczynski E. Keratoconus and Fuchs' corneal endothelial dystrophy in a patient and her family. Arch Ophthalmol 1990;108:993-4 (Pubitemid 20216021)
35. Orlin SE, Raber IM, Eagle RC, Jr, Scheie HG. Keratoconus associated with corneal endothelial dystrophy. Cornea 1990;9:299-304 (Pubitemid 20308057)
36. Jurkunas U, Azar DT. Potential complications of ocular surgery in patients with coexistent keratoconus and Fuchs' endothelial dystrophy. Ophthalmology 2006;113:2187-97 (Pubitemid 44838932)
37. Rao GP, Kaye SB, Agius-Fernandez A. Central corneal endothelial guttae and age-related macular degeneration: is there an association? Indian J Ophthalmol 1998;46:145-7 (Pubitemid 128519390)
38. Olsen T. Is there an association between Fuchs' endothelial dystrophy and cardiovascular disease? Graefes Arch Clin Exp Ophthalmol 1984;221:239-40 (Pubitemid 14114990)
39. Burns RR, Bourne WM, Brubaker RF. Endothelial function in patients with cornea guttata. Invest Ophthalmol Vis Sci 1981;20:77-85 (Pubitemid 11062154)
40. Wilson SE, Bourne WM, O'Brien PC, Brubaker RF. Endothelial function and aqueous humor flow rate in patients with Fuchs' dystrophy. Am J Ophthalmol 1988;106:270-8
41. Bergmanson JP, Sheldon TM, Goosey JD. Fuchs' endothelial dystrophy: a fresh look at an aging disease. Ophthalmic Physiol Opt 1999;19:210-22 (Pubitemid 29134655)
42. McCartney MD, Wood TO, McLaughlin BJ. Moderate Fuchs' endothelial dystrophy ATPase pump site density. Invest Ophthalmol Vis Sci 1989;30:1560-4 (Pubitemid 19185958)
43. Klintworth GK. Corneal dystrophies. Orphanet J Rare Diseases 2009;4:7
44. Wulle KG. Electron microscopy of the fetal development of the corneal endothelium and Descemet's membrane of the human eye. Invest Ophthalmol 1972;11:897-904
45. Murphy C, Alvarado J, Juster R. Prenatal and postnatal growth of the human Descemet's membrane. Invest Ophthalmol Vis Sci 1984;25:1402-15 (Pubitemid 15191095)
46. Johnson DH, Bourne WM, Campbell RJ. The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas. Arch Ophthalmol 1982;100:1942-7 (Pubitemid 13240996)
47. Gottsch JD, Zhang C, Sundin OH, et al. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene. Invest Ophthalmol Vis Sci 2005;46:4504-11 (Pubitemid 44264546)
48. Zhang C, Bell WR, Sundin OH, et al. Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation. Trans Am Ophthalmol Soc 2006;104:85-97
49. Bourne WM, Johnson DH, Campbell RJ. The ultrastructure of Descemet's membrane. III. Fuchs' dystrophy. Arch Ophthalmol 1982;100:1952-5 (Pubitemid 13240998)
50. Levy SG, Moss J, Sawada H, et al. The composition of wide-spaced collagen in normal and diseased Descemet's membrane. Curr Eye Res 1996;15:45-52 (Pubitemid 26046658)
51. Waring GO III. Posterior collagenous layer of the cornea. Ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol 1982;100:122-34
52. Sawada H, Konomi H, Hirosawa K. Characterization of the collagen in the hexagonal lattice of Descemet's membrane: its relation to type VIII collagen. J Cell Biol 1990;110:219-27
53. Jakus MA. Studies on the cornea. II. The fine structure of Descement's membrane. J Biophys Biochem Cytol 1956;2:243-52
54. Levy SG, McCartney AC, Sawada H, et al. Descemet's membrane in the iridocorneal-endothelial syndrome: morphology and composition. Exp Eye Res 1995;61:323-333.
55. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 2001;10:2415-23 (Pubitemid 33069547)
56. Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy. Invest Ophthalmol Vis Sci 2005;46:1934-9
57. Mok JW, Kim HS, Joo CK. Q455V mutation in COL8A2 is associated with Fuchs' corneal dystrophy in Korean patients. Eye 2009;23:895-903
58. Kobayashi A, Fujiki K, Murakami A, et al. Analysis of COL8A2 gene mutation in Japanese patients with Fuchs' endothelial dystrophy and posterior polymorphous dystrophy. Jpn J Ophthalmol 2004;48:195-8 (Pubitemid 38691425)
59. Aldave AJ, Rayner SA, Salem AK, et al. No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci 2006;47:3787-90 (Pubitemid 46044292)
60. Hopfer U, Fukai N, Hopfer H, et al. Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. Faseb J 2005;19:1232-44 (Pubitemid 41113720)
61. Murphy C, Alvarado J, Juster R. Prenatal and postnatal growth of the human Descemet's membrane. Invest Ophthalmol Vis Sci 1984;25:1402-15 (Pubitemid 15191095)
62. Park M, Li Q, Shcheynikov N, et al. NaBC 1 is a ubiquitous electrogenic Na+ -coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol Cell 2004;16:331-41 (Pubitemid 39504788)
63. Parker MD, Ourmozdi EP, Tanner MJ. Human BTR1, a new bicarbonate transporter superfamily member and human AE 4 from kidney. Biochem Biophys Res Commun 2001;282:1103-9 (Pubitemid 32912838)
64. Vithana EN, Morgan P, Sundaresan P, et al. Mutations in sodiumborate cotransporter SLC 4A11 cause recessive congenital hereditary endothelial dystrophy (CHE D2). Nat Genet 2006;38:755-7 (Pubitemid 43980595)
65. Lopez IA, Rosenblatt MI, Kim C, et al. Slc4a11 gene disruption in mice: Cellular targets of sensorineuronal abnormalities. J Biol Chem 2009;284:26882-96
66. Sundin OH, Jun AS, Broman KW, et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13. Invest Ophthalmol Vis Sci 2006;47:140-5 (Pubitemid 46780806)
67. Sundin OH, Broman KW, Chang HH, et al. A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32. Invest Ophthalmol Vis Sci 2006;47:3919-26 (Pubitemid 46044307)
68. Riazuddin SA, Eghrari AO, Al-Saif A, et al. Linkage of a mild lateonset phenotype of Fuchs corneal dystrophy to a novel locus at 5q33.1-q35.2. Invest Ophthalmol Vis Sci 2009;50:5667-71
69. Afshari NA, Li YJ, Pericak-Vance MA, Gregory S, Klintworth GK. Genome-wide linkage scan in fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2009;50:1093-7
70. Borderie VM, Lopez M, Lombet A, et al. Cryopreservation and culture of human corneal keratocytes. Invest Ophthalmol Vis Sci 1998;39:1511-9 (Pubitemid 28307379)
71. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci 1998;39:220-6
72. Bourcier T, Borderie V, Forgez P, et al. In vitro effects of dexamethasone on human corneal keratocytes. Invest Ophthalmol Vis Sci 1999;40:1061-70 (Pubitemid 29211443)
73. Nickells RW, Zack DJ. Apoptosis in ocular disease: a molecular overview. Ophthalmic Genet 1996;17:145-65 (Pubitemid 27067555)
74. Tempestini A, Schiavone N, Papucci L, et al. The mechanisms of apoptosis in biology and medicine: a new focus for ophthalmology. Eur J Ophthalmol 2003;13 Suppl 3:S11-8
75. Borderie VM, Baudrimont M, Vallee A, et al. Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci 2000;41:2501-5 (Pubitemid 30624376)
76. Waring GO III, Mbekeani JN. Corneal dystrophies, in Leibowitz HM, Waring GO III (eds); Corneal disorders: clinical diagnosis and management. Philadelphia, WB Saunders, 1998, pp 227-28
77. Li QJ, Ashraf MF, Shen DF, et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol 2001;119:1597-1604 (Pubitemid 33035700)
78. Szentmary N, Szende B, Suveges I. P53, CD95, cathepsin and survivin pathways in Fuchs' dystrophy and pseudophakic bullous keratopathy corneas. Histol Histopathol 2008;23:911-6
79. Engler C, Kelliher C, Spitze AR, et al. Unfolded protein response in Fuchs endothelial corneal dystrophy: A Unifying Pathogenic Pathway? Am J Ophthalmol 2010;149:194-202
80. Gottsch JD, Bowers AL, Margulies EH, et al. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest Ophthalmol Vis Sci 2003;44:594-9 (Pubitemid 36159704)
81. Tuberville AW, Wood TO, McLaughlin BJ. Cytochrome oxidase activity of Fuchs' endothelial dystrophy. Curr Eye Res 1986;5:939-47 (Pubitemid 17219043)
82. Jurkunas UV, Bitar M, Rawe I. Colocalization of increased transforming growth factor-beta-induced protein (TGFB Ip) and Clusterin in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2009;50:1129-36
83. Jurkunas UV, Bitar MS, Rawe I, et al. Increased clusterin expression in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 2008;49:2946-55
84. Jurkunas UV, Rawe I, Bitar MS, et al. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 2008;49:2956-63
85. Pucci S, Bonanno E, Pichiorri F, et al. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004;23:2298-2304 (Pubitemid 38496784)
86. Criswell T, Beman M, Araki S, et al. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. J Biol Chem 2005;280:14212-21 (Pubitemid 40517323)
87. Lidstrom AM, Bogdanovic N, Hesse C, et al. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 1998;154:511-21 (Pubitemid 29044220)
88. Trougakos IP, So A, Jansen B, et al. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004;64:1834-42 (Pubitemid 38428709)
89. Viard I, Wehrli P, Jornot L, et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 1999;112:290-6 (Pubitemid 29125103)
90. Yang CR, Leskov K, Hosley-Eberlein K, et al. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci U S A 2000;97:5907-12 (Pubitemid 30367497)
91. Reddy KB, Jin G, Karode MC, et al. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 1996;35:6157-63 (Pubitemid 26147589)
92. Caccamo AE, Scaltriti M, Caporali A, et al. Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann N Y Acad Sci 2003;1010:514-9 (Pubitemid 38265036)
93. Schwochau GB, Nath KA, Rosenberg ME. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 1998;53:1647-53 (Pubitemid 28243748)
94. Bates RC, Buret A, van Helden DF, et al. Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994;125:403-15 (Pubitemid 24135953)
95. Runager K, Enghild JJ, Klintworth GK. Focus on molecules: Transforming growth factor beta induced protein (TGFB Ip). Exp Eye Res 2008;87:298-9
96. Hashimoto K, Noshiro M, Ohno S, et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CA P/beta ig-h3) that binds to collagen. Biochim Biophys Acta 1997;1355:303-14 (Pubitemid 27091386)
97. Billings PC, Whitbeck JC, Adams CS, et al. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem 2002;277:28003-9 (Pubitemid 34966750)
98. LeBaron RG, Bezverkov KI, Zimber MP, et al. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995;104:844-9
99. Kim JE, Kim SJ, Lee BH, et al. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem 2000;275:30907-15
100. Watabe S, Hiroi T, Yamamoto Y, et al. SP-22 is a thioredox-independent peroxide reductase in mitochondria. Eur J Biochem 1997;249:52-60 (Pubitemid 27432595)
101. Zhang P, Liu B, Kang SW, et al. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 1997;272:30615-8 (Pubitemid 27527491)
102. Kang SW, Chae HZ, Seo MS, et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998;273:6297-302 (Pubitemid 28144719)
103. Krapfenbauer K, Engidawork E, Cairns N, et al. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 2003;967:152-60 (Pubitemid 36324297)
104. Kim SH, Fountoulakis M, Cairns N, Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 2001;223-35 (Pubitemid 38085085)
105. Chae HZ, Robison K, Poole LB, et al. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 1994;91:7017-21 (Pubitemid 24226793)
106. Zhou Y, Kok KH, Chun AC, et al. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 2000;268:921-7 (Pubitemid 30150892)
107. Chae HZ, Kim IH, Kim K, Rhee SG. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem 1993;268:16815-21 (Pubitemid 23229999)
108. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002;50:341-51 (Pubitemid 34173022)
109. Wang Z, Handa JT, Green WR, et al. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. Ophthalmology 2007;114:1453-60 (Pubitemid 47126573)
110. Bitar MS, Jurkunas UV. Antioxidant gene profiling and oxidative DNA damage in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2009;50:E-Abstract 3889
111. Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 1995;333:638-44
112. Online Mendelian inheritance in man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). {6/15/2009}. World Wide Web URL: http://www.ncbi.nlm.nih.gov/ omim/